We've found
184,457
clinical trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heterozygous Familial Hypercholesterolemia Clinical Trial
Trial Assessing Efficacy, Safety and Tolerability of PCSK9 Inhibition in Paediatric Subjects With Genetic LDL Disorders
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Renal Impairment Clinical Trial
A Study Evaluating the Pharmacokinetics of Doravirine in Participants With Severe Renal Impairment (MK-1439-051)
Status: Enrolling,
Phase
I
Updated: 3/18/2016
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 2/28/2017
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Negative-Pressure Wound Therapy Clinical Trial
Negative Pressure Wound Therapy in Post-Operative Incision Management
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Status: Enrolling,
Phase
II
Updated: 1/11/2018
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
CNS Tumor Clinical Trial
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
CNS Tumor Clinical Trial
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Intracranial Hemorrhage Ruptured Aneurysm Clinical Trial
International Subarachnoid Aneurysm Trial II
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
GIOTRIF rPMS in Korean Patients With NSCLC
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heterozygous Familial Hypercholesterolemia Clinical Trial
Updated: 12/31/1969
Trial Assessing Efficacy, Safety and Tolerability of PCSK9 Inhibition in Paediatric Subjects With Genetic LDL Disorders
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 1/11/2018
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
Status: Enrolling,
Phase
III
Updated: 1/11/2018
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Updated: 9/14/2017
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling,
Phase
IV
Updated: 9/14/2017
Click here to add this to my saved trials
Renal Impairment Clinical Trial
Updated: 3/18/2016
A Study Evaluating the Pharmacokinetics of Doravirine in Participants With Severe Renal Impairment (MK-1439-051)
Status: Enrolling,
Phase
I
Updated: 3/18/2016
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Updated: 2/28/2017
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 2/28/2017
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Dysmenorrhea Clinical Trial
Updated: 7/27/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Negative-Pressure Wound Therapy Clinical Trial
Updated: 12/31/1969
Negative Pressure Wound Therapy in Post-Operative Incision Management
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Updated: 1/11/2018
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Status: Enrolling,
Phase
II
Updated: 1/11/2018
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Updated: 12/31/1969
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Updated: 12/31/1969
Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
CNS Tumor Clinical Trial
Updated: 12/31/1969
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
CNS Tumor Clinical Trial
Updated: 12/31/1969
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Intracranial Hemorrhage Ruptured Aneurysm Clinical Trial
Updated: 12/31/1969
International Subarachnoid Aneurysm Trial II
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 11/17/2016
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Updated: 11/21/2016
GIOTRIF rPMS in Korean Patients With NSCLC
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials